< Back to companies
Sweetch (סוויטש בריאות)

Sweetch (סוויטש בריאות)

Ramat Gan, Israel

Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change. Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2013
Website
www.sweetch.com/

Categories

AI / MLCardiovascular DiseaseDiabetes
Only accessible to MedStartr community members. Join now

What do you think of Sweetch (סוויטש בריאות)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now